Transmitted drug resistance in French HIV-2-infected patients

被引：12

作者：

Charpentier, Charlotte ^{[1
]}

Visseaux, Benoit ^{[1
]}

Benard, Antoine ^{[2
]}

Peytavin, Gilles ^{[3
]}

Damond, Florence ^{[1
]}

Roy, Celine ^{[2
]}

Taieb, Audrey ^{[2
]}

Chene, Genevieve ^{[2
]}

Matheron, Sophie ^{[4
]}

Brun-Vezinet, Francoise ^{[1
]}

Descamps, Diane ^{[1
]}

机构：

[1] Univ Paris 07, Grp Hosp Bichat Claude Bernard, AP HP, HUPNVS,PRES Sorbonne Paris Cite,Lab Virol, Paris, France

[2] Bordeaux Segalen Univ, ISPED, INSERM, U897, Bordeaux, France

[3] Univ Paris 07, Grp Hosp Bichat Claude Bernard, AP HP, HUPNVS,PRES Sorbonne Paris Cite,Lab Pharmacol, Paris, France

[4] Univ Paris 07, Grp Hosp Bichat Claude Bernard, AP HP,HUPNVS,PRES Sorbonne Paris Cite, Serv Malad Infect & Trop, Paris, France

来源：

AIDS | 2013年 / 27卷 / 10期

关键词：

IMMUNODEFICIENCY-VIRUS TYPE-2; HIV-2; INFECTED-PATIENTS; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; MUTATIONS; SURVEILLANCE; PREVALENCE; SUSCEPTIBILITY; MULTICENTER; SELECTION;

D O I：

10.1097/QAD.0b013e32836207f3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report the first transmitted drug resistance survey study in HIV-2-infected patients living in France. The prevalence of transmitted drug resistance was 5.0% (95% confidence interval, 0.1-9.9) with mutations detected only in protease, not in reverse transcriptase. In this series, 10% of patients displayed X4/dual-mixed viruses. These findings classified the rate of transmitted drug resistance in the HIV-2 French Cohort as low prevalence.

引用

页码：1671 / 1674

页数：4

共 50 条

[41] Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program
Descamps, Diane
Peytavin, Gilles
Visseaux, Benoit
Tubiana, Roland
Damond, Florence
Campa, Pauline
Charpentier, Charlotte
Khuong-Josses, Marie-Aude
Duvivier, Claudine
Karmochkine, Marina
Lukiana, Tuna
Matheron, Sophie
CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) : 1521 - 1527
[42] Antiretroviral drug resistance in HIV-infected patients in Colombia
DiazGranados, Carlos A.
Mantilla, Monica
Lenis, William
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (04) : E298 - E303
[43] Drug resistance among patients recently infected with HIV - Reply
Little, SJ
Richman, DD
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (23): : 1889 - 1890
[44] HCV DRUG RESISTANCE MUTATIONS IN HIV-INFECTED PATIENTS
Reingardt, D. E.
Ostankova, Yu V.
Anufrieva, E. V.
Semenov, A., V
Lyalina, L., V
Totolian, A. A.
INFEKTSIYA I IMMUNITET, 2024, 14 (01): : 86 - 94
[45] Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance
Rhee, Soo-Yon
Schapiro, Jonathan M. M.
Saladini, Francesco
Zazzi, Maurizio
Khoo, Saye
Shafer, Robert W. W.
AIDS RESEARCH AND THERAPY, 2023, 20 (01)
[46] AUTOLOGOUS NEUTRALIZING ANTIBODIES AND VIRAL LOAD IN HIV-2-INFECTED INDIVIDUALS
TAMALET, C
SIMON, F
DHIVER, C
MATHERON, S
DEMICCO, P
GASTAO, JA
BRUNVEZINET, F
AIDS, 1995, 9 (01) : 90 - 91
[47] Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance
Soo-Yon Rhee
Jonathan M. Schapiro
Francesco Saladini
Maurizio Zazzi
Saye Khoo
Robert W. Shafer
AIDS Research and Therapy, 20
[48] Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients
van der Ende, ME
Prins, AM
Brinkman, K
Keuter, M
Veenstra, A
Danner, SA
Niesters, HGM
Osterhaus, ADME
Schutten, M
AIDS, 2003, 17 : S55 - S61
[49] Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients
Damond, Florence
Lariven, Sylvie
Roquebert, Benedicte
Males, Sylvia
Peytavin, Gilles
Morau, Genevieve
Toledano, Daniel
Descamps, Diane
Brun-Vezinet, Francoise
Matheron, Sophie
AIDS, 2008, 22 (05) : 665 - 666
[50] HIV drug resistance among nave HIV-infected patients in Iran
Farrokhi, Molood
Gholami, Mohammad
Mohraz, Minoo
McFarland, Willi
Baesi, Kazem
Abbasian, Ladan
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2019, 24

← 1 2 3 4 5 →